(Q62571320)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10626357%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Specificity of platinum-DNA adduct repair (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10626357%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10626357%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

S G Chaney

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10626357%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

publication date

1 October 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10626357%20AND%20SRC:MED&resulttype=core&format=json

Journal of Inorganic Biochemistry

3 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10626357%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

77

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10626357%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10626357%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

71-81

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10626357%20AND%20SRC:MED&resulttype=core&format=json

Nonclassical platinum antitumor agents: perspectives for design and development of new drugs complementary to cisplatin

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900149-X

7 January 2021

DNA binding properties of [Pt(NH3)(C6H11NH2)Cl2], a metabolite of an orally active platinum anticancer drug

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900149-X

7 January 2021

Cross-resistance, cisplatin accumulation, and platinum-DNA adduct formation and removal in cisplatin-sensitive and -resistant human hepatoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900149-X

7 January 2021

Decreased drug accumulation and increased tolerance to DNA damage in tumor cells with a low level of cisplatin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900149-X

7 January 2021

Purification and domain-mapping of mammalian DNA polymerase beta.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900149-X

7 January 2021

Thymine-thymine dimer bypass by yeast DNA polymerase zeta

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900149-X

7 January 2021

Characterization of the native and recombinant catalytic subunit of human DNA polymerase gamma: identification of residues critical for exonuclease activity and dideoxynucleotide sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900149-X

7 January 2021

Cisplatin-DNA binding specificity of calf high-mobility group 1 protein

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900149-X

7 January 2021

Replication inhibition and translesion synthesis on templates containing site- specifically placed cis-diamminedichloroplatinum(II) DNA adducts

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900149-X

7 January 2021

Rodent UV-sensitive mutant cell lines in complementation groups 6-10 have normal general excision repair activity

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900149-X

7 January 2021

Fork-like DNA templates support bypass replication of lesions that block DNA synthesis on single-stranded templates

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900149-X

7 January 2021

In vitro bypass replication of the cisplatin-d(GpG) lesion by calf thymus DNA polymerase beta and human immunodeficiency virus type I reverse transcriptase is highly mutagenic

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900149-X

7 January 2021

Enhanced DNA repair as a mechanism of resistance to cis-diamminedichloroplatinum(II).

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900149-X

7 January 2021

Increased gene specific repair of cisplatin induced interstrand crosslinks in cisplatin resistant cell lines, and studies on carrier ligand specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900149-X

7 January 2021

DNA repair in cells sensitive and resistant to cis-diamminedichloroplatinum(II): host cell reactivation of damaged plasmid DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900149-X

7 January 2021

Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900149-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900149-X

1 reference

7 January 2021

Pathways of human cell post-replication repair

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900149-X

7 January 2021

The RAD6 DNA repair pathway in Saccharomyces cerevisiae: what does it do, and how does it do it?

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900149-X

7 January 2021

Roadblocks and detours during DNA replication: mechanisms of mutagenesis in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900149-X

7 January 2021

Role of DNA replication in carrier-ligand-specific resistance to platinum compounds in L1210 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900149-X

7 January 2021

Effects of DNA adduct structure and distribution on the mutagenicity and genotoxicity of two platinum anticancer drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900149-X

7 January 2021

Crystal structure of rat DNA polymerase beta: evidence for a common polymerase mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900149-X

7 January 2021

Structural and functional insights provided by crystal structures of DNA polymerases and their substrate complexes.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900149-X

7 January 2021

Requirement of yeast DNA polymerase delta in post-replicational repair of UV-damaged DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900149-X

7 January 2021

DNA polymerase beta bypasses in vitro a single d(GpG)-cisplatin adduct placed on codon 13 of the HRAS gene

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900149-X

7 January 2021

Effects of the anticancer drug cis-diamminedichloroplatinum(II) on the activities of calf thymus DNA polymerase epsilon

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900149-X

7 January 2021

Overexpression of DNA polymerase beta in cell results in a mutator phenotype and a decreased sensitivity to anticancer drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900149-X

7 January 2021

A human homolog of the Saccharomyces cerevisiae REV3 gene, which encodes the catalytic subunit of DNA polymerase zeta

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900149-X

7 January 2021

Effect of DNA polymerases and high mobility group protein 1 on the carrier ligand specificity for translesion synthesis past platinum-DNA adducts

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900149-X

7 January 2021

Cisplatin and adriamycin resistance are associated with MutLalpha and mismatch repair deficiency in an ovarian tumor cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900149-X

7 January 2021

Microsatellite instability in ovarian neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900149-X

7 January 2021

Mismatch repair: mechanisms and relationship to cancer susceptibility

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900149-X

7 January 2021

Recognition and repair of compound DNA lesions (base damage and mismatch) by human mismatch repair and excision repair systems

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900149-X

7 January 2021

Selective recognition of a cisplatin-DNA adduct by human mismatch repair proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900149-X

7 January 2021

HMG1 protein inhibits the translesion synthesis of the major DNA cisplatin adduct by cell extracts

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900149-X

7 January 2021

Characterization of a DNA damage-recognition protein from mammalian cells that binds specifically to intrastrand d(GpG) and d(ApG) DNA adducts of the anticancer drug cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900149-X

7 January 2021

The XPA protein is a zinc metalloprotein with an ability to recognize various kinds of DNA damage

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900149-X

7 January 2021

Binding of tsHMG, a mouse testis-specific HMG-domain protein, to cisplatin-DNA adducts

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900149-X

7 January 2021

Specific binding of chromosomal protein HMG1 to DNA damaged by the anticancer drug cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900149-X

7 January 2021

Cisplatin-DNA adducts are molecular decoys for the ribosomal RNA transcription factor hUBF (human upstream binding factor).

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900149-X

7 January 2021

Human testis-determining factor SRY binds to the major DNA adduct of cisplatin and a putative target sequence with comparable affinities.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900149-X

7 January 2021

Human Ku autoantigen binds cisplatin-damaged DNA but fails to stimulate human DNA-activated protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900149-X

7 January 2021

Cisplatin- and UV-damaged DNA lure the basal transcription factor TFIID/TBP.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900149-X

7 January 2021

The major chromatin protein histone H1 binds preferentially to cis-platinum-damaged DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900149-X

7 January 2021

Cisplatin-DNA adducts inhibit ribosomal RNA synthesis by hijacking the transcription factor human upstream binding factor

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900149-X

7 January 2021

HMG-domain proteins specifically inhibit the repair of the major DNA adduct of the anticancer drug cisplatin by human excision nuclease

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900149-X

7 January 2021

Expression of hMSH2 correlates with in vitro chemosensitivity to CDDP cytotoxicity in oral and oropharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2899%2900149-X

7 January 2021

10.1016/S0162-0134(99)00149-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10626357%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference